CCR4 antagonists
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 5, 2006
Grant Date -
Jan 23, 2003
app pub date -
May 22, 2002
filing date -
May 23, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Compounds, compositions and methods are provided that are useful in the treatment of chemokine receptor-mediated conditions and diseases. In particular, the invention provides compounds which modulate CCR4 function or a CCR4-mediated response. The subject compounds and compositions are useful for the treatment or prevention of inflammatory conditions and diseases.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully